![]() |
JOURNAL TOOLS |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |

YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW FOCUS ON 64CU: RADIOPHARMACEUTICALS AND CLINICAL APPLICATIONS
The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 December;64(4):382-92
DOI: 10.23736/S1824-4785.20.03277-X
Copyright © 2020 EDIZIONI MINERVA MEDICA
language: English
Copper, PET/CT and prostate cancer: a systematic review of the literature
Arnoldo PICCARDO 1 ✉, Martina UGOLINI 1, Sergio RIGHI 2, Gianluca BOTTONI 1, Angelina CISTARO 1, Francesco PAPARO 3, Luca GIOVANELLA 4, Laura EVANGELISTA 5
1 Department of Nuclear Medicine, EO Ospedali Galliera, Genoa, Italy; 2 Medical Physics Department, EO Ospedali Galliera, Genoa, Italy; 3 Department of Radiology, EO Ospedali Galliera, Genoa, Italy; 4 Clinic for Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; 5 Nuclear Medicine Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy
Copper is an essential element that plays an important role in both cancer development and growth. Indeed, high levels of copper have been found in prostate cancer (PCa), and this finding have paved the way for the use of this element as a target for positron emission tomography (PET) imaging. Copper64 (64Cu) can be used alone, as 64CuCl
KEY WORDS: Copper; Positron emission tomography computed tomography; Prostatic neoplasms